ロード中...
A targeted extracorporeal therapy for endotoxemia: the time has come
Endotoxemia, whether primary (due to Gram-negative infection) or secondary (due to epithelial barrier dysfunction), appears to be extremely common in the critically ill and injured. High levels of endotoxin activity are associated with worse clinical outcomes. In Japan, polymyxin B hemoperfusion has...
保存先:
| 第一著者: | |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2007
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2206410/ https://ncbi.nlm.nih.gov/pubmed/17567925 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/cc5918 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|